Received Mar 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Hives all over body still almost 2 months later; This serious case was reported by a consumer and described the occurrence of hives in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 31-JAN-2025, the patient received Shingrix. On 31-JAN-2025, less than a day after receiving Shingrix, the patient experienced hives (Verbatim: Hives all over body still almost 2 months later) (serious criteria clinically significant/intervention required). The patient was treated with Steroids. The outcome of the hives was not resolved. It was unknown if the reporter considered the hives to be related to Shingrix. It was unknown if the company considered the hives to be related to Shingrix. Additional Information: GSK Receipt Date:21-FEB-2026 The patient had completed two rounds of steroid pills prescribed by the first doctor, received one steroid from the dermatologist, and used a 0.25 percent cream. After almost two months, it was (hives) still present, and the patient was unsure what to did next. The batch number was not provided, and we are unable to contact the reporter.